[Anticoagulation in pregnancy].
Coma-Canella
I
I
Unidad Coronaria, Hospital La Paz, Madrid.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000022:Abortion, Spontaneous / Q000139:chemically induced; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D003374:Coumarins / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D006349:Heart Valve Diseases / Q000188:drug therapy*; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011446:Prospective Studies; D013924:Thrombophlebitis / Q000188:drug therapy*
D000925:Anticoagulants; D003374:Coumarins; D010975:Platelet Aggregation Inhibitors; D006493:Heparin
Anticoagulación en el embarazo.